Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 91


Acyclovir Has Low but Detectable Influence on HLA-B*57:01 Specificity without Inducing Hypersensitivity.

Metushi IG, Wriston A, Banerjee P, Gohlke BO, English AM, Lucas A, Moore C, Sidney J, Buus S, Ostrov DA, Mallal S, Phillips E, Shabanowitz J, Hunt DF, Preissner R, Peters B.

PLoS One. 2015 May 29;10(5):e0124878. doi: 10.1371/journal.pone.0124878. eCollection 2015.


Super Natural II--a database of natural products.

Banerjee P, Erehman J, Gohlke BO, Wilhelm T, Preissner R, Dunkel M.

Nucleic Acids Res. 2015 Jan;43(Database issue):D935-9. doi: 10.1093/nar/gku886. Epub 2014 Oct 9.


GenderMedDB: an interactive database of sex and gender-specific medical literature.

Oertelt-Prigione S, Gohlke BO, Dunkel M, Preissner R, Regitz-Zagrosek V.

Biol Sex Differ. 2014 May 23;5:7. doi: 10.1186/2042-6410-5-7. eCollection 2014.


SuperPred: update on drug classification and target prediction.

Nickel J, Gohlke BO, Erehman J, Banerjee P, Rong WW, Goede A, Dunkel M, Preissner R.

Nucleic Acids Res. 2014 Jul;42(Web Server issue):W26-31. doi: 10.1093/nar/gku477. Epub 2014 May 30.


ProTox: a web server for the in silico prediction of rodent oral toxicity.

Drwal MN, Banerjee P, Dunkel M, Wettig MR, Preissner R.

Nucleic Acids Res. 2014 Jul;42(Web Server issue):W53-8. doi: 10.1093/nar/gku401. Epub 2014 May 16.


Polymorphic cytochrome P450 enzymes (CYPs) and their role in personalized therapy.

Preissner SC, Hoffmann MF, Preissner R, Dunkel M, Gewiess A, Preissner S.

PLoS One. 2013 Dec 10;8(12):e82562. doi: 10.1371/journal.pone.0082562. eCollection 2013. Review.


The Transformer database: biotransformation of xenobiotics.

Hoffmann MF, Preissner SC, Nickel J, Dunkel M, Preissner R, Preissner S.

Nucleic Acids Res. 2014 Jan;42(Database issue):D1113-7. doi: 10.1093/nar/gkt1246. Epub 2013 Dec 10.


mVOC: a database of microbial volatiles.

Lemfack MC, Nickel J, Dunkel M, Preissner R, Piechulla B.

Nucleic Acids Res. 2014 Jan;42(Database issue):D744-8. doi: 10.1093/nar/gkt1250. Epub 2013 Dec 5.


SuperPain--a resource on pain-relieving compounds targeting ion channels.

Gohlke BO, Preissner R, Preissner S.

Nucleic Acids Res. 2014 Jan;42(Database issue):D1107-12. doi: 10.1093/nar/gkt1176. Epub 2013 Nov 22.


Residues of a proposed gate region in type I ATP-binding cassette import systems are crucial for function as revealed by mutational analysis.

Weidlich D, Wiesemann N, Heuveling J, Wardelmann K, Landmesser H, Sani KB, Worth CL, Preissner R, Schneider E.

Biochim Biophys Acta. 2013 Sep;1828(9):2164-72. doi: 10.1016/j.bbamem.2013.05.032. Epub 2013 Jun 6. Erratum in: Biochim Biophys Acta. 2014 May;1838(5):1448.


A new algorithm for integrated analysis of miRNA-mRNA interactions based on individual classification reveals insights into bladder cancer.

Hecker N, Stephan C, Mollenkopf HJ, Jung K, Preissner R, Meyer HA.

PLoS One. 2013 May 24;8(5):e64543. doi: 10.1371/journal.pone.0064543. Print 2013.


Targeted therapy of the XIAP/proteasome pathway overcomes TRAIL-resistance in carcinoma by switching apoptosis signaling to a Bax/Bak-independent 'type I' mode.

Gillissen B, Richter A, Richter A, Overkamp T, Essmann F, Hemmati PG, Preissner R, Belka C, Daniel PT.

Cell Death Dis. 2013 May 23;4:e643. doi: 10.1038/cddis.2013.67.


VaccImm: simulating peptide vaccination in cancer therapy.

von Eichborn J, Woelke AL, Castiglione F, Preissner R.

BMC Bioinformatics. 2013 Apr 15;14:127. doi: 10.1186/1471-2105-14-127.


Mapping discontinuous protein-binding sites via structure-based peptide libraries: combining in silico and in vitro approaches.

Jaeger IS, Kretzschmar I, Körner J, Weiser AA, Mahrenholz CC, Potty A, Kourentzi K, Willson RC, Volkmer R, Preissner R.

J Mol Recognit. 2013 Jan;26(1):23-31. doi: 10.1002/jmr.2237.


Drug cocktail optimization in chemotherapy of cancer.

Preissner S, Dunkel M, Hoffmann MF, Preissner SC, Genov N, Rong WW, Preissner R, Seeger K.

PLoS One. 2012;7(12):e51020. doi: 10.1371/journal.pone.0051020. Epub 2012 Dec 7.


SynSysNet: integration of experimental data on synaptic protein-protein interactions with drug-target relations.

von Eichborn J, Dunkel M, Gohlke BO, Preissner SC, Hoffmann MF, Bauer JM, Armstrong JD, Schaefer MH, Andrade-Navarro MA, Le Novere N, Croning MD, Grant SG, van Nierop P, Smit AB, Preissner R.

Nucleic Acids Res. 2013 Jan;41(Database issue):D834-40. doi: 10.1093/nar/gks1040. Epub 2012 Nov 11.


SuperTarget goes quantitative: update on drug-target interactions.

Hecker N, Ahmed J, von Eichborn J, Dunkel M, Macha K, Eckert A, Gilson MK, Bourne PE, Preissner R.

Nucleic Acids Res. 2012 Jan;40(Database issue):D1113-7. doi: 10.1093/nar/gkr912. Epub 2011 Nov 8.


Binding sites in membrane proteins--diversity, druggability and prospects.

Adams R, Worth CL, Guenther S, Dunkel M, Lehmann R, Preissner R.

Eur J Cell Biol. 2012 Apr;91(4):326-39. doi: 10.1016/j.ejcb.2011.06.003. Epub 2011 Aug 27. Review.


Development of immune-specific interaction potentials and their application in the multi-agent-system VaccImm.

Woelke AL, von Eichborn J, Murgueitio MS, Worth CL, Castiglione F, Preissner R.

PLoS One. 2011;6(8):e23257. doi: 10.1371/journal.pone.0023257. Epub 2011 Aug 17.


SDM--a server for predicting effects of mutations on protein stability and malfunction.

Worth CL, Preissner R, Blundell TL.

Nucleic Acids Res. 2011 Jul;39(Web Server issue):W215-22. doi: 10.1093/nar/gkr363. Epub 2011 May 18.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk